Quantcast
 
Search for: Search what?
Nov 26, 2009  
 Sections
Latest New Product News
Industry Market Trends
Green & Clean News
Association & Government News
Adhesives and Sealants
Agricultural and Farming Products
Architectural and Civil Engineering Products
Automatic ID
Chemical Processing and Waste Management
Cleaning Products and Equipment
Communication Systems and Equipment
Computer Hardware and Peripherals
Construction Equipment and Supplies
Controls and Controllers
Display and Presentation Equipment
Electrical Equipment and Systems
Electronic Components and Devices
Explosives, Armaments and Weaponry
Fasteners and Hardware
Fluid and Gas Flow Equipment
Food Processing and Preparation
Health, Medical and Dental Supplies and Equipment
HVAC
Labels, Tags, Signage and Equipment
Laboratory and Research Supplies and Equipment
Lubricants
Machinery and Machining Tools
Material Handling and Storage
Materials and Material Processing
Mechanical Components and Assemblies
Mechanical Power Transmission
Mining, Oil Drilling & Refining
Mounting and Attaching Products
Non-Industrial Products
Optics and Photonics
Packaging Products & Equipment
Paints and Coatings
Plant Furnishings and Accessories
Portable Tools
Printing and Duplicating Equipment
Retail and Sales Equipment
Robotics
Safety and Security Equipment
Sensors, Monitors and Transducers
Services
Software
Test and Measuring Instruments
Textile Industry Products
Thermal and Heating Equipment
Timers and Clocks
Transportation Industry Products
Vision Systems
Waste Handling Equipment
Welding Equipment and Supplies
 Press Releases
Products in the News
Company News
Mergers & Acquisitions
People in the News
Literature & Websites
 Resources
News Delivery Options
Browse Categories
Browse Companies
Mobile Edition
PR Resources
Licensing
Advertising
How to Write an effective Press Release
Trade Associations
Small Business Support
MEP
Advertisement

Absorbable Sutures eliminate use of knots.


August 23, 2007 - Quill(TM) Self-Retaining System (SRS) MONODERM(TM) sutures are made from rapidly resorbing polymer, which is intended primarily for superficial wound closure applications. Available in 3 diameters, FDA-approved products feaure helical barbed design that enables surgeons to suture without use of knots. This minimizes complications associated with knots and promotes wound healing as well as cosmesis. During procedures, sutures let surgeon control tension and enable suturing in tight places.

(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)

 See related product stories
Large Platen Press uses heat to seal medical packaging.
 See more product news in:
Health, Medical and Dental Supplies and Equipment
 Tools for you
del.icio.us DIGG  
Facebook Reddit
StumbleUpon Twitter
Print This Page E-Mail Story
Watch_Company  Save Story
View Company Profile
Company web site 
More news from this company

Advertisement
More Tools and information
Search for suppliers of
Medical Equipment Sealing
Join the forum discussion at:
 Tools of the Trade
 Newsletters
Your Gateway to a Fast Changing World
Product News Alerts
Receive similar stories and other customized news to keep you in the know on the products shaping industry.
Subscribe Free Today
Subscribe   View Sample

Industry Market Trends
Has Got It
  • Latest developments
  • Trends
  • Best practices
  • Opinions & Commentary
Get Ahead. Get IMT.
Subscribe Free Today
Subscribe   View Sample


Angiotech Announces Expansion of Innovative Quill(TM) SRS Product Line with New Choice of Absorbable Sutures


VANCOUVER, Aug. 13 -- Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPI)(NASDAQ:TSX:)(NASDAQ:ANP), a global specialty pharmaceutical and medical device company, today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to begin marketing a new polymer line of absorbable sutures, further broadening the offering of the Quill(TM) Self-Retaining System (SRS) product line.

Angiotech is launching MONODERM(TM), a new line of Quill(TM) SRS sutures made from a rapidly resorbing polymer, which is intended primarily for superficial wound closure applications. The Quill(TM) SRS MONODERM(TM) sutures will be available in three different diameters.

"Since the initial launch of Quill(TM) SRS, we have received a tremendous amount of positive feedback and many requests to offer new iterations of the product line," said Dr. William Hunter, President and CEO of Angiotech. "We believe that these new, fast-degrading sutures are a great complement to the existing Quill(TM) SRS product line," added Dr. Hunter.

Angiotech intends to continue to expand the Quill(TM) SRS product line to cover multiple procedures for wound closure and tissue approximation.

It is expected that Angiotech will launch Quill(TM) SRS MONODERM(TM) in the fall, with plans to exhibit the Quill(TM) SRS product line at the Annual Meeting of the American Society of Plastic Surgeons (ASPS) to be held on October 26-31, 2007 in Baltimore, MD.

About the Quill(TM) Self-Retaining System (SRS)

The innovative Quill(TM) SRS represents the next generation of wound closure technology. A patented helical barbed design enables surgeons to suture without the use of knots. The absence of knots provides a wide range of clinical and economic benefits, including:

Potential to improve patient outcomes:

- Minimizes complications associated with knots
- Potential to improve wound healing
- May enhance cosmesis

Potential to save time in the operating room:

- Achieves potentially significant time savings, especially in suture intensive procedures

Enhanced procedural techniques:

- Allows closure of difficult wounds
- Enables suturing in tight places
- Allows the surgeon to control tension

Quill (TM) is a trademark of Quill Medical, Inc., a wholly-owned subsidiary of Angiotech Pharmaceuticals, Inc.

MONODERM(TM) is a trademark of Surgical Specialties Corporation, a wholly-owned subsidiary of Angiotech Pharmaceuticals, Inc.

About Angiotech

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech (NASDAQ:ANPI)(NASDAQ:TSX:)(NASDAQ:ANP), please visit our website at www.angiotech.com.

CONTACT: Jodi Regts, Manager, Investor Relations and Corporate Communications, Angiotech Pharmaceuticals, Inc., (604) 221-7930, jregts@angio.com

Company Information:
Name: Angiotech Pharmaceuticals, Inc.
Address: 1618 Station Street, V6A 1B6
City: Vancouver BC
Country: Canada
Phone: 604-221-7676
http://www.angiotech.com


More New Product News from this company:
Self-Retaining System facilitates wound closure.

Other News from this company:
Athersys and Angiotech Announce Authorization of Phase I Intramyocardial Stem Cell U.S. Clinical Trial in Acute Myocardial Infarction
Angiotech Receives European Approval for Quill® SRS Wound Closure Product
Angiotech to Market Vascular Wrap(TM)/e0PTFE Graft Combination Product through its Own European Sales and Distribution Networks
Angiotech's Corporate Partner, Boston Scientific, Announces Japanese Launch of TAXUS® Express2(TM) Coronary Stent System
Angiotech's Corporate Partner, Boston Scientific, Announces Japanese Approval for the TAXUS® Express2(TM) Stent System



Click here for copyright permissions!
Copyright 2009 Thomas Publishing Company


 

Post a comment about this story

Name:
E-mail:
(your e-mail address will not be posted)
Comment title:
Comment:
 

Category Advertisements

Home  |  My ThomasNet News  |  Industry Market Trends  |  Submit Release  |  Advertise  |  Contact News  |  About Us
Brought to you by Thomasnet.com        Browse ThomasNet Directory

Copyright © 2009 Thomas Publishing Company
Terms of Use - Privacy Policy